Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 5
2003 17
2004 29
2005 50
2006 68
2007 84
2008 95
2009 124
2010 129
2011 143
2012 146
2013 155
2014 170
2015 149
2016 101
2017 124
2018 126
2019 123
2020 157
2021 154
2022 129
2023 107
2024 90
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,204 results

Results by year

Filters applied: . Clear all
Page 1
Advances in the study of exosomes derived from mesenchymal stem cells and cardiac cells for the treatment of myocardial infarction.
Liu Y, Wang M, Yu Y, Li C, Zhang C. Liu Y, et al. Cell Commun Signal. 2023 Aug 14;21(1):202. doi: 10.1186/s12964-023-01227-9. Cell Commun Signal. 2023. PMID: 37580705 Free PMC article. Review.
Conventional reperfusion therapy can further aggravate myocardial injury. Stem cell therapy, especially with mesenchymal stem cells (MSCs), has emerged as a promising approach to promote cardiac repair and improve cardiac function. ...The presen …
Conventional reperfusion therapy can further aggravate myocardial injury. Stem cell therapy, especially with mesenchymal …
The beneficial effects of mesenchymal stem cells and their exosomes on myocardial infarction and critical considerations for enhancing their efficacy.
Ala M. Ala M. Ageing Res Rev. 2023 Aug;89:101980. doi: 10.1016/j.arr.2023.101980. Epub 2023 Jun 10. Ageing Res Rev. 2023. PMID: 37302757 Review.
Mesenchymal stem cells (MSCs) are multipotent stromal cells with regenerative, anti-inflammatory, and immunomodulatory properties. MSCs and their exosomes significantly improved structural and functional alterations after myocardial infarctio …
Mesenchymal stem cells (MSCs) are multipotent stromal cells with regenerative, anti-inflammatory, and immunomodu …
Mesenchymal stromal cells for improvement of cardiac function following acute myocardial infarction: a matter of timing.
Barrère-Lemaire S, Vincent A, Jorgensen C, Piot C, Nargeot J, Djouad F. Barrère-Lemaire S, et al. Physiol Rev. 2024 Apr 1;104(2):659-725. doi: 10.1152/physrev.00009.2023. Epub 2023 Aug 17. Physiol Rev. 2024. PMID: 37589393 Free article. Review.
Acute myocardial infarction (AMI) is the leading cause of cardiovascular death and remains the most common cause of heart failure. ...Due to their biological properties, the use of mesenchymal stromal/stem cells (MSCs) has been considered a pote …
Acute myocardial infarction (AMI) is the leading cause of cardiovascular death and remains the most common cause of heart fail …
Stem cell therapy for acute myocardial infarction: Mesenchymal Stem Cells and induced Pluripotent Stem Cells.
Clavellina D, Balkan W, Hare JM. Clavellina D, et al. Expert Opin Biol Ther. 2023 Jul-Dec;23(10):951-967. doi: 10.1080/14712598.2023.2245329. Epub 2023 Aug 30. Expert Opin Biol Ther. 2023. PMID: 37542462 Free PMC article. Review.
INTRODUCTION: Acute myocardial infarction (AMI) remains a leading cause of death in the United States. The limited capacity of cardiomyocytes to regenerate and the restricted contractility of scar tissue after AMI are not addressed by current pharmacologic intervent …
INTRODUCTION: Acute myocardial infarction (AMI) remains a leading cause of death in the United States. The limited capacity of …
Mesenchymal stem cell-derived exosomes in cardiovascular and cerebrovascular diseases: From mechanisms to therapy.
Pan Y, Wu W, Jiang X, Liu Y. Pan Y, et al. Biomed Pharmacother. 2023 Jul;163:114817. doi: 10.1016/j.biopha.2023.114817. Epub 2023 May 2. Biomed Pharmacother. 2023. PMID: 37141733 Free article. Review.
In recent years, the focus of research has shifted from the use of mesenchymal stem cells (MSCs) for transplantation to the use of their secretory exosomes (MSC-exosomes) for the treatment of numerous CVDs, including atherosclerosis, myocardial infa …
In recent years, the focus of research has shifted from the use of mesenchymal stem cells (MSCs) for transplantation to …
Intracellular delivery of nitric oxide enhances the therapeutic efficacy of mesenchymal stem cells for myocardial infarction.
Hao T, Ji G, Qian M, Li QX, Huang H, Deng S, Liu P, Deng W, Wei Y, He J, Wang S, Gao W, Li T, Cheng J, Tian J, Pan L, Gao F, Li Z, Zhao Q. Hao T, et al. Sci Adv. 2023 Dec;9(48):eadi9967. doi: 10.1126/sciadv.adi9967. Epub 2023 Nov 29. Sci Adv. 2023. PMID: 38019911 Free PMC article.
Cell therapy by autologous mesenchymal stem cells (MSCs) is a clinically acceptable strategy for treating various diseases. ...The enhanced therapeutic efficacy of engineered MSCs combined with intracellular NO delivery was further confirmed in mouse and rat …
Cell therapy by autologous mesenchymal stem cells (MSCs) is a clinically acceptable strategy for treating various disea …
Stem cell therapy for acute myocardial infarction - focusing on the comparison between Muse cells and mesenchymal stem cells.
Yamada Y, Minatoguchi S, Kanamori H, Mikami A, Okura H, Dezawa M, Minatoguchi S. Yamada Y, et al. J Cardiol. 2022 Jul;80(1):80-87. doi: 10.1016/j.jjcc.2021.10.030. Epub 2021 Dec 17. J Cardiol. 2022. PMID: 34924234 Free article. Review.
Rapid percutaneous coronary intervention for acute myocardial infarction (AMI) reduces acute mortality, but there is an urgent need for treatment of left ventricular dysfunction and remodeling after AMI to improve the prognosis. ...It has been reported that bone mar …
Rapid percutaneous coronary intervention for acute myocardial infarction (AMI) reduces acute mortality, but there is an urgent …
Atorvastatin enhances the therapeutic efficacy of mesenchymal stem cells-derived exosomes in acute myocardial infarction via up-regulating long non-coding RNA H19.
Huang P, Wang L, Li Q, Tian X, Xu J, Xu J, Xiong Y, Chen G, Qian H, Jin C, Yu Y, Cheng K, Qian L, Yang Y. Huang P, et al. Cardiovasc Res. 2020 Feb 1;116(2):353-367. doi: 10.1093/cvr/cvz139. Cardiovasc Res. 2020. PMID: 31119268 Free PMC article.
AIMS: Naturally secreted nanovesicles, known as exosomes, play important roles in stem cell-mediated cardioprotection. We have previously demonstrated that atorvastatin (ATV) pretreatment improved the cardioprotective effects of mesenchymal stem cells …
AIMS: Naturally secreted nanovesicles, known as exosomes, play important roles in stem cell-mediated cardioprotection. We have previo …
Mechanistic effects of mesenchymal and hematopoietic stem cells: New therapeutic targets in myocardial infarction.
Shafei AE, Ali MA, Ghanem HG, Shehata AI, Abdelgawad AA, Handal HR, ElSayed AS, Ashaal AE, Ali MM, El-Shal AS. Shafei AE, et al. J Cell Biochem. 2018 Jul;119(7):5274-5286. doi: 10.1002/jcb.26637. Epub 2018 Mar 12. J Cell Biochem. 2018. PMID: 29266431 Review.
Myocardial infarction (MI) results in dysfunction and irreversible loss of cardiomyocytes and is of the most serious health threats today. Mesenchymal stem cells (MSCs) and hematopoietic stem cells (HSCs) have been explored as prom …
Myocardial infarction (MI) results in dysfunction and irreversible loss of cardiomyocytes and is of the most serious health th …
The Vital Roles of Mesenchymal Stem Cells and the Derived Extracellular Vesicles in Promoting Angiogenesis After Acute Myocardial Infarction.
Zhang LL, Xiong YY, Yang YJ. Zhang LL, et al. Stem Cells Dev. 2021 Jun 1;30(11):561-577. doi: 10.1089/scd.2021.0006. Epub 2021 Apr 30. Stem Cells Dev. 2021. PMID: 33752473 Review.
Acute myocardial infarction (AMI) is an event of ischemic myocardial necrosis caused by acute coronary artery occlusion, which ultimately leads to a large loss of cardiomyocytes. ...Recently, growing evidence based on promising preclinical data indicates that …
Acute myocardial infarction (AMI) is an event of ischemic myocardial necrosis caused by acute coronary artery occlusion …
2,204 results